# Zebra Technologies Corp: financial statements, quarterly ZBRA · Nasdaq · CIK 877212 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/zbra.md) · [Financials](/companies/zbra/financials.md) · [Filings](/companies/zbra/filings.md) · [Insiders](/companies/zbra/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zbra/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [956](/filings/0000877212-24-000164.md) | [1,009 d](/filings/0001628280-26-007668.md) | [1,175](/filings/0000877212-25-000065.md) | [1,217](/filings/0000877212-25-000131.md) | [1,255](/filings/0001628280-25-046778.md) | [1,334 d](/filings/0001628280-26-007668.md) | [1,308](/filings/0001628280-26-034109.md) | [1,293](/filings/0001628280-26-052550.md) | [1,320](/filings/0001628280-25-046778.md) | [1,475 d](/filings/0001628280-26-007668.md) | [1,495](/filings/0001628280-26-034109.md) | [1,557](/filings/0001628280-26-052550.md) | | Cost of revenue | $m | [529](/filings/0000877212-24-000164.md) | [561 d](/filings/0001628280-26-007668.md) | [612](/filings/0000877212-25-000065.md) | [628](/filings/0000877212-25-000131.md) | [642](/filings/0001628280-25-046778.md) | [686 d](/filings/0001628280-26-007668.md) | [663](/filings/0001628280-26-034109.md) | [677](/filings/0001628280-26-052550.md) | [686](/filings/0001628280-25-046778.md) | [777 d](/filings/0001628280-26-007668.md) | [753](/filings/0001628280-26-034109.md) | [732](/filings/0001628280-26-052550.md) | | Gross profit | $m | [427](/filings/0000877212-24-000164.md) | [448 d](/filings/0001628280-26-007668.md) | [563](/filings/0000877212-25-000065.md) | [589](/filings/0000877212-25-000131.md) | [613](/filings/0001628280-25-046778.md) | [648 d](/filings/0001628280-26-007668.md) | [645](/filings/0001628280-26-034109.md) | [616](/filings/0001628280-26-052550.md) | [634](/filings/0001628280-25-046778.md) | [698 d](/filings/0001628280-26-007668.md) | [742](/filings/0001628280-26-034109.md) | [825](/filings/0001628280-26-052550.md) | | Research and development | $m | [127](/filings/0000877212-24-000164.md) | [116 d](/filings/0001628280-26-007668.md) | [138](/filings/0000877212-25-000065.md) | [146](/filings/0000877212-25-000131.md) | [141](/filings/0001628280-25-046778.md) | [138 d](/filings/0001628280-26-007668.md) | [151](/filings/0001628280-26-034109.md) | [144](/filings/0001628280-26-052550.md) | [146](/filings/0001628280-25-046778.md) | [152 d](/filings/0001628280-26-007668.md) | [165](/filings/0001628280-26-034109.md) | [159](/filings/0001628280-26-052550.md) | | Operating income | $m | [(12.0)](/filings/0000877212-24-000164.md) | [74.0 d](/filings/0001628280-26-007668.md) | [159](/filings/0000877212-25-000065.md) | [167](/filings/0000877212-25-000131.md) | [191](/filings/0001628280-25-046778.md) | [225 d](/filings/0001628280-26-007668.md) | [195](/filings/0001628280-26-034109.md) | [183](/filings/0001628280-26-052550.md) | [183](/filings/0001628280-25-046778.md) | [139 d](/filings/0001628280-26-007668.md) | [215](/filings/0001628280-26-034109.md) | [321](/filings/0001628280-26-052550.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(9.0)](/filings/0000877212-24-000164.md) | [(15.0) d](/filings/0001628280-26-007668.md) | [27.0](/filings/0000877212-25-000065.md) | [23.0](/filings/0000877212-25-000131.md) | [12.0](/filings/0001628280-25-046778.md) | [45.0 d](/filings/0001628280-26-007668.md) | [29.0](/filings/0001628280-26-034109.md) | [26.0](/filings/0001628280-26-052550.md) | [58.0](/filings/0001628280-25-046778.md) | [28.0 d](/filings/0001628280-26-007668.md) | [32.0](/filings/0001628280-26-034109.md) | [52.0](/filings/0001628280-26-052550.md) | | Net income | $m | [(15.0)](/filings/0000877212-24-000164.md) | [17.0 d](/filings/0001628280-26-007668.md) | [115](/filings/0001628280-25-046778.md) | [113](/filings/0001628280-25-046778.md) | [137](/filings/0001628280-25-046778.md) | [163 d](/filings/0001628280-26-007668.md) | [136](/filings/0001628280-26-052550.md) | [112](/filings/0001628280-26-052550.md) | [101](/filings/0001628280-25-046778.md) | [70.0 d](/filings/0001628280-26-007668.md) | [135](/filings/0001628280-26-052550.md) | [233](/filings/0001628280-26-052550.md) | | Diluted EPS | $ per share | [(0.28)](/filings/0000877212-24-000164.md) | not reported | [2.23](/filings/0000877212-25-000065.md) | [2.17](/filings/0000877212-25-000131.md) | [2.64](/filings/0001628280-25-046778.md) | not reported | [2.62](/filings/0001628280-26-034109.md) | [2.19](/filings/0001628280-26-052550.md) | [1.97](/filings/0001628280-25-046778.md) | not reported | [2.72](/filings/0001628280-26-034109.md) | [4.85](/filings/0001628280-26-052550.md) | | Basic EPS | $ per share | [(0.28)](/filings/0000877212-24-000164.md) | not reported | [2.24](/filings/0000877212-25-000065.md) | [2.19](/filings/0000877212-25-000131.md) | [2.65](/filings/0001628280-25-046778.md) | not reported | [2.64](/filings/0001628280-26-034109.md) | [2.20](/filings/0001628280-26-052550.md) | [1.98](/filings/0001628280-25-046778.md) | not reported | [2.74](/filings/0001628280-26-034109.md) | [4.89](/filings/0001628280-26-052550.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [61.0](/filings/0000877212-24-000164.md) | [137](/filings/0001628280-26-007668.md) | [127](/filings/0000877212-25-000065.md) | [411](/filings/0000877212-25-000131.md) | [676](/filings/0001628280-25-046778.md) | [901](/filings/0001628280-26-007668.md) | [879](/filings/0000877212-25-000065.md) | [872](/filings/0000877212-25-000131.md) | [1,053](/filings/0001628280-25-046778.md) | [125](/filings/0001628280-26-052550.md) | [114](/filings/0001628280-26-034109.md) | [157](/filings/0001628280-26-052550.md) | | Current assets | $m | [1,652](/filings/0000877212-23-000143.md) | [1,672](/filings/0000877212-25-000027.md) | [1,627](/filings/0000877212-24-000063.md) | [1,953](/filings/0000877212-24-000151.md) | [2,133](/filings/0000877212-24-000164.md) | [2,440](/filings/0001628280-26-007668.md) | [2,291](/filings/0000877212-25-000065.md) | [2,334](/filings/0000877212-25-000131.md) | [2,576](/filings/0001628280-25-046778.md) | [1,796](/filings/0001628280-26-052550.md) | [1,695](/filings/0001628280-26-034109.md) | [2,062](/filings/0001628280-26-052550.md) | | Total assets | $m | [7,331](/filings/0000877212-23-000143.md) | [7,306](/filings/0000877212-25-000027.md) | [7,259](/filings/0000877212-24-000063.md) | [7,490](/filings/0000877212-24-000151.md) | [7,690](/filings/0000877212-24-000164.md) | [7,968](/filings/0001628280-26-007668.md) | [7,899](/filings/0000877212-25-000065.md) | [7,938](/filings/0000877212-25-000131.md) | [8,067](/filings/0001628280-25-046778.md) | [8,502](/filings/0001628280-26-052550.md) | [8,332](/filings/0001628280-26-034109.md) | [8,637](/filings/0001628280-26-052550.md) | | Current liabilities | $m | [1,562](/filings/0000877212-23-000143.md) | [1,598](/filings/0000877212-25-000027.md) | [1,643](/filings/0000877212-24-000063.md) | [1,522](/filings/0000877212-24-000151.md) | [1,562](/filings/0000877212-24-000164.md) | [1,704](/filings/0001628280-26-007668.md) | [1,581](/filings/0000877212-25-000065.md) | [1,594](/filings/0000877212-25-000131.md) | [1,603](/filings/0001628280-25-046778.md) | [1,852](/filings/0001628280-26-052550.md) | [1,763](/filings/0001628280-26-034109.md) | [3,998](/filings/0001628280-26-052550.md) | | Total liabilities | $m | [4,318](/filings/0000877212-23-000143.md) | [4,270](/filings/0000877212-25-000027.md) | [4,090](/filings/0000877212-24-000063.md) | [4,203](/filings/0000877212-24-000151.md) | [4,269](/filings/0000877212-24-000164.md) | [4,382](/filings/0001628280-26-007668.md) | [4,273](/filings/0000877212-25-000065.md) | [4,321](/filings/0000877212-25-000131.md) | [4,320](/filings/0001628280-25-046778.md) | [4,914](/filings/0001628280-26-052550.md) | [4,862](/filings/0001628280-26-034109.md) | [5,202](/filings/0001628280-26-052550.md) | | Long-term debt | $m | [2,121](/filings/0000877212-23-000143.md) | [2,047](/filings/0000877212-25-000027.md) | [1,815](/filings/0000877212-24-000063.md) | [2,080](/filings/0000877212-24-000151.md) | [2,080](/filings/0000877212-24-000164.md) | [2,092](/filings/0001628280-26-007668.md) | [2,103](/filings/0000877212-25-000065.md) | [2,128](/filings/0000877212-25-000131.md) | [2,107](/filings/0001628280-25-046778.md) | [2,361](/filings/0001628280-26-052550.md) | [2,387](/filings/0001628280-26-034109.md) | [493](/filings/0001628280-26-052550.md) | | Current portion of debt | $m | [152](/filings/0000877212-23-000143.md) | [173](/filings/0000877212-25-000027.md) | [272](/filings/0000877212-24-000063.md) | [89.0](/filings/0000877212-24-000151.md) | [89.0](/filings/0000877212-24-000164.md) | [79.0](/filings/0001628280-26-007668.md) | [69.0](/filings/0000877212-25-000065.md) | [44.0](/filings/0000877212-25-000131.md) | [66.0](/filings/0001628280-25-046778.md) | [141](/filings/0001628280-26-052550.md) | [264](/filings/0001628280-26-034109.md) | [2,275](/filings/0001628280-26-052550.md) | | Shareholders' equity | $m | [3,013](/filings/0000877212-24-000164.md) | [3,036](/filings/0001628280-26-007668.md) | [3,169](/filings/0001628280-25-046778.md) | [3,287](/filings/0001628280-25-046778.md) | [3,421](/filings/0001628280-25-046778.md) | [3,586](/filings/0001628280-26-052550.md) | [3,626](/filings/0001628280-26-052550.md) | [3,617](/filings/0001628280-26-052550.md) | [3,747](/filings/0001628280-25-046778.md) | [3,588](/filings/0001628280-26-052550.md) | [3,470](/filings/0001628280-26-052550.md) | [3,435](/filings/0001628280-26-052550.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(35.0) d](/filings/0000877212-24-000164.md) | [141 d](/filings/0001628280-26-007668.md) | [125](/filings/0000877212-25-000065.md) | [288 d](/filings/0000877212-25-000131.md) | [294 d](/filings/0001628280-25-046778.md) | [306 d](/filings/0001628280-26-007668.md) | [178](/filings/0001628280-26-034109.md) | [147 d](/filings/0001628280-26-052550.md) | [235 d](/filings/0001628280-25-046778.md) | [357 d](/filings/0001628280-26-007668.md) | [176](/filings/0001628280-26-034109.md) | [211 d](/filings/0001628280-26-052550.md) | | Capital expenditure | $m | [14.0 d](/filings/0000877212-24-000164.md) | [39.0 d](/filings/0001628280-26-007668.md) | [14.0](/filings/0000877212-25-000065.md) | [10.0 d](/filings/0000877212-25-000131.md) | [17.0 d](/filings/0001628280-25-046778.md) | [18.0 d](/filings/0001628280-26-007668.md) | [20.0](/filings/0001628280-26-034109.md) | [17.0 d](/filings/0001628280-26-052550.md) | [19.0 d](/filings/0001628280-25-046778.md) | [30.0 d](/filings/0001628280-26-007668.md) | [13.0](/filings/0001628280-26-034109.md) | [13.0 d](/filings/0001628280-26-052550.md) | | Share repurchases | $m | [0.0 d](/filings/0000877212-24-000164.md) | [0.0 d](/filings/0001628280-26-007668.md) | [0.0](/filings/0000877212-25-000065.md) | [0.0 d](/filings/0000877212-25-000131.md) | [16.0 d](/filings/0001628280-25-046778.md) | [31.0 d](/filings/0001628280-26-007668.md) | [125](/filings/0001628280-26-034109.md) | [125 d](/filings/0001628280-26-052550.md) | [34.0 d](/filings/0001628280-25-046778.md) | [303 d](/filings/0001628280-26-007668.md) | [300](/filings/0001628280-26-034109.md) | [268 d](/filings/0001628280-26-052550.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [52.2](/filings/0000877212-23-000143.md) | [51.7](/filings/0000877212-24-000063.md) | [51.7](/filings/0000877212-24-000151.md) | [51.3](/filings/0000877212-24-000164.md) | [51.8](/filings/0000877212-25-000065.md) | [51.8](/filings/0000877212-25-000131.md) | [51.9](/filings/0001628280-25-046778.md) | [51.8](/filings/0001628280-26-034109.md) | [51.3](/filings/0001628280-26-052550.md) | [51.2](/filings/0001628280-25-046778.md) | [49.4](/filings/0001628280-26-034109.md) | [48.1](/filings/0001628280-26-052550.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 47,310,660 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052550.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.